Mallia
Entity

  • Mallia

    Created in 2023


  • Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups

  • Social networks

    1,448 1,345

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Henkestraße 91, 91052 Erlangen, Germany

    Erlangen

    Germany

  • Employees

    Scale: 2-10

    Estimated: 16

  • Engaged catalyst

    1
    0 0

  • Added in Motherbase

    3 years, 1 month ago
Description
  • Value proposition

    Mallia develops cosmetic applications for hair growth and biopharmaceutical therapies for hair loss.

    Mallia Innovations GmbH is the holding company strategically driving the development and commercialization of cosmetic applications and biopharmaceutical therapies of the immune modulatory sCD83 protein, targeting hair growth, hair loss and other dermatological indications, including wound healing.
    Subsidiary Mallia Aesthetics GmbH focuses on the development of cosmetic products to stimulate hair growth.
    Subsidiary Mallia Therapeutics GmbH focuses on the clinical development of novel therapies for patients suffering from androgenetic alopecia or alopecia areata, among other conditions.

  • Mallia | Science, impact and values

    Insight into the world of Mallia - with sound research into hair growth and hair biology. Scientifically clear. Effect measurable.

    • https://www.mallia.com/
Catalyst interactions
Catalyst Type Tweets Articles
HTGF | High-Tech Gründerfonds
HTGF | High-Tech Gründerfonds
Venture Capital and Private Equity Principals (Auto)
HTGF | High-Tech Gründerfonds
Venture Capital and Private Equity Principals (Auto) 		Other

31 Jul 2023


Social network dynamics
Similar entities
BETA
Last news
Show all articles